JPWO2021105964A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021105964A5
JPWO2021105964A5 JP2022527775A JP2022527775A JPWO2021105964A5 JP WO2021105964 A5 JPWO2021105964 A5 JP WO2021105964A5 JP 2022527775 A JP2022527775 A JP 2022527775A JP 2022527775 A JP2022527775 A JP 2022527775A JP WO2021105964 A5 JPWO2021105964 A5 JP WO2021105964A5
Authority
JP
Japan
Prior art keywords
use according
women
hmo
breast milk
later date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022527775A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503401A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/061258 external-priority patent/WO2021105964A1/en
Publication of JP2023503401A publication Critical patent/JP2023503401A/ja
Publication of JPWO2021105964A5 publication Critical patent/JPWO2021105964A5/ja
Pending legal-status Critical Current

Links

JP2022527775A 2019-11-29 2020-11-30 妊婦の細菌叢を改善するためのhmoの混合物 Pending JP2023503401A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201901402 2019-11-29
DKPA201901402 2019-11-29
PCT/IB2020/061258 WO2021105964A1 (en) 2019-11-29 2020-11-30 Mixture of hmos for improving the microbiota of pregnant women

Publications (2)

Publication Number Publication Date
JP2023503401A JP2023503401A (ja) 2023-01-30
JPWO2021105964A5 true JPWO2021105964A5 (de) 2023-11-08

Family

ID=76130109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022527775A Pending JP2023503401A (ja) 2019-11-29 2020-11-30 妊婦の細菌叢を改善するためのhmoの混合物

Country Status (7)

Country Link
US (1) US20230012011A1 (de)
EP (1) EP4065128A4 (de)
JP (1) JP2023503401A (de)
KR (1) KR20220107011A (de)
CN (1) CN114761024A (de)
BR (1) BR112022010061A2 (de)
WO (1) WO2021105964A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115918916A (zh) * 2022-11-29 2023-04-07 黑龙江飞鹤乳业有限公司 含母乳低聚糖和乳铁蛋白的营养组合物、食品及用途
CN115843880A (zh) * 2022-11-29 2023-03-28 黑龙江飞鹤乳业有限公司 含母乳低聚糖和骨桥蛋白的营养组合物、食品及用途
CN115868632A (zh) * 2022-11-29 2023-03-31 黑龙江飞鹤乳业有限公司 含母乳低聚糖和益生菌的营养组合物、食品及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2645472C (en) * 2006-03-10 2015-09-15 N.V. Nutricia Use of non-digestable saccharides for giving an infant the best start after birth
WO2012092160A2 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
CN107106582A (zh) * 2014-09-15 2017-08-29 N·V·努特里奇亚 降低后代焦虑
MX2018007124A (es) * 2015-12-15 2018-09-07 Nestec Sa Mezcla de hmo.
CN110573030A (zh) * 2017-05-24 2019-12-13 雀巢产品有限公司 用于增强注意力和/或降低冲动的营养组合物
EP3720446A4 (de) * 2017-12-05 2021-09-15 Glycom A/S Menschliche milcholigosaccharide zur behandlung von migräne

Similar Documents

Publication Publication Date Title
Guclu et al. Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature
Patel et al. Association of ABO and Rh incompatibility with neonatal hyperbilirubinaemia
Mori et al. Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle‐aged Japanese women
JPWO2021105964A5 (de)
Cherry et al. Primary hyperparathyroidism, hypercalcemic crisis and subsequent seizures occurring during pregnancy: a case report
Baig et al. Studies on Zn, Cu, Mg, Ca and phosphorus in maternal and cord blood
Schwarzer et al. Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine
Bass et al. Trisomy 18 mosaicism: clues to the diagnosis
Conde et al. CNS siderosis and dandy-walker variant after neonatal alloimmune thrombocytopenia
Maurovich-Horvat1ABCDEF et al. Assessment of pregnancy outcomes in Czech and Slovak women with narcolepsy
EP4285378A1 (de) Verfahren zur bestimmung der personalisierten dha-ergänzung
Merlob et al. Psychotropic drugs
CN101518615B (zh) 一种治疗妊娠反应的中药组合物
Tu et al. Serotonin metabolism in normal and abnormal infants during the perinatal period
CN108310123A (zh) 一种用于预防和/或治疗高尿酸血症的药物组合物及其制备方法和用途
Evans et al. Neonatal serotonin toxicity
Doig et al. Megaloblastic anaemia during combined phensuximide and phenobarbitone therapy
JP2012530046A (ja) 出生児の出生体重の低下リスクを防ぐ妊婦用の乳由来組成物
Lundberg Hereditary Polyneuropathy, Oligophrenia, Premature Menopause and Acromicria: A New Syndrome
Monroe Menstruation, menopause, and HIV
Jatana 2 Nutrition in Women Health
Derouiche et al. Study of Socioclinical Risk Factors for Breast Milk Deficiency in Women During Lactation
CN112807392A (zh) 一种针对糖尿病前期人群的中药组合物及制备方法
Sachar et al. Primary biliary cirrhosis
Hoover et al. Drug-Nutrient Interaction Considerations in Pregnancy and Lactation